Follow
Ocular Diseases
Ocular Diseases: is any disease related to the eyes such as optic nerve disorders which including glaucoma. Retinal disorders are also another example of an ocular disease and involve problems with the nerve layer at the back of the eye. A common ocular disease is known as the dry eye syndrome, this is a condition in which a person doesn't have enough quality tears to lubricate and nourish the eye.
APR 23, 2019 | 11:00 AM
DATE: April 23, 2019TIME: 11:00am PDT, 2:00pm EDT Cataract, a clouding of the ocular lens, is the leading cause of blindness worldwide. Currently the only means of treatment i...
JAN 31, 2019 | 1:30 PM
Development of novel types of therapeutics require adaptation of traditional bioprocessing applications to include the use of primary cells, such as stem cells, fibroblasts, astrocytes and ne...
AUG 01, 2018 | 12:00 AM
Induced pluripotent stem (iPS) cells are a promising source of personalized therapy. These cells can provide immune-compatible autologous replacement tissue for the treatment of potentially a...
MAR 16, 2017 | 1:30 PM
Studying the genetics of rare congenital disorders disrupting cognitive function has led to the identification of multiple disease genes that helped us better understand the mechanisms underl...
AUG 30, 2016 | 8:00 AM
Human induced pluripotent stem cells (iPSCs) are valuable cells for retinal disease modeling, as these cells are of patient origin and can be differentiated into cell types of interest. This ...
AUG 21, 2014 | 8:45 AM
Gene therapy for two forms of inherited retinal degeneration have met promising safety and efficacy endpoints in early stage clinical trials. These approaches made use of a replication defect...
AUG 30, 2016 | 8:00 AM
Human induced pluripotent stem cells (iPSCs) are valuable cells for retinal disease modeling, as these cells are of patient origin and can be differentiated into cell types of interest. This ...
AUG 21, 2014 | 8:45 AM
Gene therapy for two forms of inherited retinal degeneration have met promising safety and efficacy endpoints in early stage clinical trials. These approaches made use of a replication defect...